The different prognostic impact of type-1 or type-1 like and type-2 or type-2 like CALR mutations in patients with primary myelofibrosis

被引：10
作者：
不详
机构：
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2016年 / 91卷 / 07期
关键词：
CALRETICULIN MUTATIONS; MPL; 1-LIKE; JAK2;
D O I：
10.1002/ajh.24378
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E320 / E321
页数：4
相关论文
共 6 条
[1]   Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis [J].
Guglielmelli, P. ;
Rotunno, G. ;
Fanelli, T. ;
Pacilli, A. ;
Brogi, G. ;
Calabresi, L. ;
Pancrazzi, A. ;
Vannucchi, A. M. .
BLOOD CANCER JOURNAL, 2015, 5 :e360-e360
[2]   Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis [J].
Marty, Caroline ;
Pecquet, Christian ;
Nivarthi, Harini ;
El-Khoury, Mira ;
Chachoua, Ilyas ;
Tulliez, Micheline ;
Villeval, Jean-Luc ;
Raslova, Hana ;
Kralovics, Robert ;
Constantinescu, Stefan N. ;
Plo, Isabelle ;
Vainchenker, William .
BLOOD, 2016, 127 (10) :1317-1324
[3]   Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis [J].
Rumi, Elisa ;
Pietra, Daniela ;
Pascutto, Cristiana ;
Guglielmelli, Paola ;
Martinez-Trillos, Alejandra ;
Casetti, Ilaria ;
Colomer, Dolors ;
Pieri, Lisa ;
Pratcorona, Marta ;
Rotunno, Giada ;
Sant'Antonio, Emanuela ;
Bellini, Marta ;
Cavalloni, Chiara ;
Mannarelli, Carmela ;
Milanesi, Chiara ;
Boveri, Emanuela ;
Ferretti, Virginia ;
Astori, Cesare ;
Rosti, Vittorio ;
Cervantes, Francisco ;
Barosi, Giovanni ;
Vannucchi, Alessandro M. ;
Cazzola, Mario .
BLOOD, 2014, 124 (07) :1062-1069
[4]   Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact [J].
Tefferi, A. ;
Lasho, T. L. ;
Finke, C. ;
Belachew, A. A. ;
Wassie, E. A. ;
Ketterling, R. P. ;
Hanson, C. A. ;
Pardanani, A. .
LEUKEMIA, 2014, 28 (07) :1568-1570
[5]   CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons [J].
Tefferi, A. ;
Lasho, T. L. ;
Finke, C. M. ;
Knudson, R. A. ;
Ketterling, R. ;
Hanson, C. H. ;
Maffioli, M. ;
Caramazza, D. ;
Passamonti, F. ;
Pardanani, A. .
LEUKEMIA, 2014, 28 (07) :1472-1477
[6]   The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants [J].
Tefferi, Ayalew ;
Lasho, Terra L. ;
Tischer, Alexander ;
Wassie, Emnet A. ;
Finke, Christy M. ;
Belachew, Alem A. ;
Ketterling, Rhett P. ;
Hanson, Curtis A. ;
Pardanani, Animesh D. .
BLOOD, 2014, 124 (15) :2465-2466
1